ProQR Therapeutics BV (PRQR) — Capital Reinvestment Ratio
Latest as of March 2023:
0.00x
ProQR Therapeutics BV (PRQR) has a Capital Reinvestment Ratio of 0.00x as of March 2023, meaning it reinvests 0% of its operating cash flow ($44.73 Million) in capital expenditures ($136.00K). See PRQR cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
$44.73 Million
USD
Capital Expenditures
$136.00K
USD
Data as of
Mar 2023
Most recent filing
ProQR Therapeutics BV Capital Reinvestment Ratio (2023–2023)
This chart tracks ProQR Therapeutics BV's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for ProQR Therapeutics BV (2023–2023)
Year-by-year Capital Reinvestment Ratio for ProQR Therapeutics BV from 2023 to 2023. For live market cap and broader valuation context, see ProQR Therapeutics BV market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.06x | $21.55 Million | $1.37 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow